CN102949555B - Medicine for treating diabetic feet - Google Patents

Medicine for treating diabetic feet Download PDF

Info

Publication number
CN102949555B
CN102949555B CN201210449880.1A CN201210449880A CN102949555B CN 102949555 B CN102949555 B CN 102949555B CN 201210449880 A CN201210449880 A CN 201210449880A CN 102949555 B CN102949555 B CN 102949555B
Authority
CN
China
Prior art keywords
parts
medicine
liquid
minutes
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201210449880.1A
Other languages
Chinese (zh)
Other versions
CN102949555A (en
Inventor
马锋振
张文生
王震
徐宁
周翠玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Binzhou Medical University Hospital
Original Assignee
Binzhou Medical University Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Binzhou Medical University Hospital filed Critical Binzhou Medical University Hospital
Priority to CN201210449880.1A priority Critical patent/CN102949555B/en
Publication of CN102949555A publication Critical patent/CN102949555A/en
Application granted granted Critical
Publication of CN102949555B publication Critical patent/CN102949555B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a medicine for treating diabetic feet. The medicine is prepared by the following crude medicines in parts by weight: 30-40 parts of peach kernel, 20-30 parts of sufflower, 20-30 parts of angelica sinensis, 20-30 parts of rehmanniae vaporata, 20-30 parts of sanguis draconis, 20-30 parts of cassia twig, 20-30 parts of phellodendron amurense, 20-30 parts of honeysuckle, 10-20 parts of astragalus mongholicus, 5-10 parts of semen raphani and 5-10 parts of gypsum. A preparation method comprises the following steps of: soaking the raw materials for 2-3 hours with water, decocting for 30 minutes, pouring out medicine liquid, then adding water, boiling for 30 minutes, pouring out medicine liquid, and combining the two types of medicine liquid to obtain the medicine. Pharmaceutically-accepted carriers are added to a traditional Chinese medicinal composite of the medicine for preparing an accepted preparation, such as granules, powders, capsules, oral liquid and pills. After composition, the medicine has the advantages that the effect has synergistic action, the treating effect is exact and the adverse reaction is less.

Description

A kind of medicine for the treatment of diabetic foot
Technical field
The present invention relates to a kind of Chinese medicine composition, specifically relating to is a kind of medicine for the treatment of diabetic foot.
Background technology
Diabetic foot (dinbetic foot, DF) is the pathological changes general names such as the dark ulcer of foot pain, skin that causes of diabetes composite factor, acromelic gangrene, is one of chronic complicating diseases of diabetes, and severe patient needs amputation, and amputation rate is up to 40%.Its main manifestations is acral pain, suppurative infection, ulcer, gangrene.Once morbidity, because its treatment is complicated, difficulty is large, the course of disease is long, be difficult for healing, can face the consequences such as amputation, death.Its medical expense is also much higher than the diabetics same period of being in hospital because of other reasons, so diabetic foot pathological changes is one of the most fearful severe complication of diabetes.
Summary of the invention
The object of the invention is, for overcoming above-mentioned the deficiencies in the prior art, provides a kind of medicine for the treatment of diabetic foot.
For achieving the above object, the present invention adopts following technical proposals:
Treat a medicine for diabetic foot, it is to be made by the crude drug of following weight portion: Semen Persicae 30-40 part, Flos Carthami 20-30 part, Radix Angelicae Sinensis 20-30 part, Radix Rehmanniae Preparata 20-30 part, Sanguis Draxonis 20-30 part, Ramulus Cinnamomi 20-30 part, Cortex Phellodendri 20-30 part, Flos Lonicerae 20-30 part, Radix Astragali 10-20 part, Semen Raphani 5-10 part, Gypsum Fibrosum 5-10 part.
The preferred weight proportioning of above-mentioned Chinese medicine composition is: 35 parts, Semen Persicae, 25 parts, Flos Carthami, 25 parts of Radix Angelicae Sinensis, 25 parts, Radix Rehmanniae Preparata, 25 parts of Sanguis Draxonis, 25 parts of Ramulus Cinnamomi, 25 parts of Cortex Phellodendris, 25 parts of Flos Loniceraes, 15 parts of the Radixs Astragali, 8 parts of Semen Raphanis, 8 parts, Gypsum Fibrosum.
Preparation method is by the raw material 2-3 hour that is soaked in water, and decocts 30 minutes, pours out medicinal liquid, then adds decocting in water 30 minutes, pours out medicinal liquid, and twice medicinal liquid merges and get final product.
Chinese medicine composition of the present invention adds medicine acceptable carrier, according to the routine techniques of preparation, is prepared into any acceptable dosage form, as granule, powder, capsule, oral liquid, pill etc.
After drug regimen of the present invention, drug effect has synergism, determined curative effect, and untoward reaction is little.
The specific embodiment
Below in conjunction with embodiment, the present invention is further described.
Embodiment 1
Treat a medicine for diabetic foot, it is to be made by the crude drug of following weight portion: 35 parts, Semen Persicae, 25 parts, Flos Carthami, 25 parts of Radix Angelicae Sinensis, 25 parts, Radix Rehmanniae Preparata, 25 parts of Sanguis Draxonis, 25 parts of Ramulus Cinnamomi, 25 parts of Cortex Phellodendris, 25 parts of Flos Loniceraes, 15 parts of the Radixs Astragali, 8 parts of Semen Raphanis, 8 parts, Gypsum Fibrosum.。
Preparation method is that raw material is soaked in water 2.5 hours, decocts 30 minutes, pours out medicinal liquid, then adds decocting in water 30 minutes, pours out medicinal liquid, and twice medicinal liquid merges and get final product.Get above-mentioned medicinal liquid 500ml, decoct to 200ml, minute 2 to 3 decoction being taken warmly, 1-2 month course for the treatment of.
Treatment group adopts the medicine of embodiment 1 preparation, observes it to promoting the effect of the growth of diabetic foot ulcers granulation, promotion wound healing, and it is local that matched group adopts 0.9% saline to add insulin (adding insulin 2-4U in 10ml saline) external application ulcer, every day 1-2 time.Observation item is granulation tissue time of occurrence (GT), healing (HT), amputation rate and mortality rate.Through clinical verification (treatment time is half a year), treatment group has significant difference with respect to matched group, can think that it can promote wound repair and determined curative effect.

Claims (2)

1. treat a medicine for diabetic foot, it is to be made by the crude drug of following weight portion:
Semen Persicae 30-40 part, Flos Carthami 20-30 part, Radix Angelicae Sinensis 20-30 part, Radix Rehmanniae Preparata 20-30 part, Sanguis Draxonis 20-30 part, Ramulus Cinnamomi 20-30 part, Cortex Phellodendri 20-30 part, Flos Lonicerae 20-30 part, Radix Astragali 10-20 part, Semen Raphani 5-10 part, Gypsum Fibrosum 5-10 part.
2. the medicine for the treatment of diabetic foot as claimed in claim 1, it is characterized in that, it is to be made by the crude drug of following weight portion: 35 parts, Semen Persicae, 25 parts, Flos Carthami, 25 parts of Radix Angelicae Sinensis, 25 parts, Radix Rehmanniae Preparata, 25 parts of Sanguis Draxonis, 25 parts of Ramulus Cinnamomi, 25 parts of Cortex Phellodendris, 25 parts of Flos Loniceraes, 15 parts of the Radixs Astragali, 8 parts of Semen Raphanis, 8 parts, Gypsum Fibrosum.
CN201210449880.1A 2012-11-12 2012-11-12 Medicine for treating diabetic feet Expired - Fee Related CN102949555B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210449880.1A CN102949555B (en) 2012-11-12 2012-11-12 Medicine for treating diabetic feet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210449880.1A CN102949555B (en) 2012-11-12 2012-11-12 Medicine for treating diabetic feet

Publications (2)

Publication Number Publication Date
CN102949555A CN102949555A (en) 2013-03-06
CN102949555B true CN102949555B (en) 2014-08-20

Family

ID=47759314

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210449880.1A Expired - Fee Related CN102949555B (en) 2012-11-12 2012-11-12 Medicine for treating diabetic feet

Country Status (1)

Country Link
CN (1) CN102949555B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103893326A (en) * 2014-03-26 2014-07-02 叶葵 Traditional Chinese medicine for treating diabetic foot ulcer
CN105327058A (en) * 2015-11-02 2016-02-17 中国人民解放军第四军医大学 Anti-infection heal-promoting ointment for diabetic feet and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1682809A (en) * 2005-02-22 2005-10-19 黄资源 Strong antipruritic pill for treating obstinate pruritus of dermatosis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1682809A (en) * 2005-02-22 2005-10-19 黄资源 Strong antipruritic pill for treating obstinate pruritus of dermatosis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
于秀辰等.糖尿病足治法及用药分析.《中国中医药信息杂志》.2000,第7卷(第11期),
糖尿病足治法及用药分析;于秀辰等;《中国中医药信息杂志》;20001130;第7卷(第11期);43-44 *

Also Published As

Publication number Publication date
CN102949555A (en) 2013-03-06

Similar Documents

Publication Publication Date Title
CN101843787B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843694B (en) Chinese medicament for treating chronic hepatitis
CN102949555B (en) Medicine for treating diabetic feet
CN101843804A (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN102000250B (en) Black-bone chicken health-care medicament as well as preparation method and applications thereof
CN102294007A (en) Medicament for treating urticaria
CN102068529A (en) Traditional Chinese medicine for treatment of prostatic hyperplasia
CN102205031B (en) Traditional Chinese medicine for treating male sterility
CN101850071A (en) Chinese medicament for treating chronic nephritis
CN101537121B (en) Chinese medicine for treating arteriosclerosis
CN103800664A (en) Traditional Chinese medicine composition for treating menopausal syndrome
CN101850015B (en) Chinese medicament for treating arteriosclerosis
CN101843693A (en) Chinese medicament for treating diabetic nephropathy
CN101884747B (en) Traditional Chinese medicine for treating chronic nephritis
CN101843718B (en) Chinese medicament for treating lupus erythematosus
CN101843705B (en) Chinese medicament for treating lupus erythematosus
CN101874851B (en) Traditional Chinese medicine for treating chronic infectious arthritis
CN101843825B (en) Chinese medicament for treating climacteric syndromes
CN101843717B (en) Chinese medicament for treating coronary disease
CN101843672B (en) Chinese medicament for treating arteriosclerosis
CN101843673B (en) Chinese medicament for treating arteriosclerosis
CN101843835B (en) Chinese medicament for treating coronary diseases
CN101843758B (en) Chinese medicament for treating coronary disease
CN102091260B (en) Chinese medicinal composition for treating bronchitis
CN102018760A (en) Traditional Chinese medicine for treating benign prostatic hyperplasia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: BINZHOU MEDICAL UNIVERSITY HOSPITAL

Free format text: FORMER OWNER: JIANG TINGTING

Effective date: 20140721

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Ma Fengzhen

Inventor after: Zhang Wensheng

Inventor after: Wang Zhen

Inventor after: Xu Ning

Inventor after: Zhou Cuiling

Inventor before: Jiang Tingting

COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 250031 JINAN, SHANDONG PROVINCE TO: 256603 BINZHOU, SHANDONG PROVINCE

Free format text: CORRECT: INVENTOR; FROM: JIANG TINGTING TO: MA FENGZHEN ZHANG WENSHENG WANG ZHEN XU NING ZHOU CUILING

TA01 Transfer of patent application right

Effective date of registration: 20140721

Address after: 256603 the Yellow River Road, Shandong, No. two, No. 661, Binzhou

Applicant after: Binzhou Medical University Hospital

Address before: 250031 No. 23 normal road, Tianqiao District, Shandong, Ji'nan

Applicant before: Jiang Tingting

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140820

Termination date: 20151112

EXPY Termination of patent right or utility model